TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-093963
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Stock transactions

Transaction 1

Security

Ordinary Shares

Action

Exercise

Date

2026-03-03

Code

M

Net shares

+5,179.0

Acquired/Disposed

Acquired

Shares Owned Before

5,650.0

Shares Owned After

10,829.0

Derivative Transactions

Transaction 1

Security

Restricted Share Units

Action

Exercise

Date

2026-03-03

Code

M

Net shares

-5,179.0

Acquired/Disposed

Disposed

Shares Owned Before

10,359.0

Shares Owned After

5,180.0

Filing's footnotes

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

2. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

3. Restricted share units were granted on March 3, 2023, with 5,179 vested on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 5,180 vesting on March 3, 2027.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.